Rivaroxaban is Associated with a Reduced Risk of Thromboembolic events and Hemorrhagic Stroke in Patient with Heart Failure: Insights from ROCKET AF

Sean Van Diepen, Anne S. Hellkamp, Manesh R. Patel, Richard C. Becker, Gunter Breithardt, Jonathan L. Halperin, Graeme J. Hankey, Christopher C. Nessel, Daniel E. Singer, Scott D. Berkowitz, Robert M. Califf, Keith A. Fox, Kenneth W. Mahaffey

    Research output: Contribution to journalAbstract/Meeting Abstract

    Original languageEnglish
    Number of pages2
    Issue number21
    Publication statusPublished - 20 Nov 2012

    Cite this